ClinicalTrials.Veeva
Menu

Find clinical trials for Leukemia in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Myeloid Leukemia
Acute Myeloid Leukemia
Lymphoid Leukemia
B-Cell Chronic Lymphocytic Leukemia
Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Myelodysplastic Syndromes

Leukemia trials near San Antonio, TX, USA:

A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

chemotherapy regimen for the treatment of B-cell acute lymphoblastic leukemia. Part 1 of the study will optimize the dose of study drug (rux...

Active, not recruiting
Leukemia
Drug: Methotrexate
Drug: Thioguanine

Phase 2

Incyte
Incyte

San Antonio, Texas, United States and 110 other locations

This is a Phase 1/2, multicenter, open-label study to evaluate the safety and efficacy of BEAM-201 in patients with relapsed/refractory T-ALL or T-LL...

Enrolling
T-Cell Lymphoblastic Leukemia/Lymphoma
Lymphoblastic Leukemia
Biological: BEAM-201

Phase 1, Phase 2

Beam Therapeutics

San Antonio, Texas, United States and 9 other locations

The purpose of this study is to determine whether the combination of pevonedistat and azacitidine improves event-free survival (EFS) when compared wi...

Active, not recruiting
Leukemia, Myeloid, Acute
Leukemia, Myelomonocytic, Chronic
Drug: Pevonedistat
Drug: Azacitidine

Phase 3

Takeda
Takeda

San Antonio, Texas, United States and 240 other locations

to patients with relapsed or refractory B-cell acute Lymphoblastic Leukemia (B-ALL). The purpose of this study is to evaluate the safety and...

Enrolling
B-cell Acute Lymphoblastic Leukemia
Biological: CLLS52
Biological: UCART22

Phase 1, Phase 2

Cellectis

San Antonio, Texas, United States and 17 other locations

with azacitidine to improve Overall Survival (OS) in Acute Myeloid Leukemia (AML) participants compared to Best Supportive Care (BSC) when g...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Cancer
Drug: Venetoclax
Drug: Azacitidine

Phase 3

AbbVie
AbbVie

San Antonio, Texas, United States and 164 other locations

This will be a multicenter Phase II open-label study of asciminib in CML-CP patients who have been previously treated with one prior ATP- binding sit...

Enrolling
Chronic Myelogenous Leukemia - Chronic Phase
Drug: asciminib

Phase 2

Novartis
Novartis

San Antonio, Texas, United States and 74 other locations

In this study, adults with newly-diagnosed Philadelphia Chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) will receive first-line t...

Active, not recruiting
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Drug: Cytarabine
Drug: Vincristine

Phase 3

Takeda
Takeda

San Antonio, Texas, United States and 91 other locations

The purpose of this study is to evaluate the efficacy and safety of acalabrutinib in combination with venetoclax and acalabrutinib in combination wit...

Active, not recruiting
Chronic Lymphocytic Leukemia
Drug: Venetoclax
Drug: Obinutuzumab

Phase 3

Acerta Pharma
Acerta Pharma

Fort Sam Houston, Texas, United States and 170 other locations

This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) who have previously receiv...

Active, not recruiting
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Drug: Idelalisib
Drug: Bendamustine

Phase 3

Loxo Oncology
Loxo Oncology

San Antonio, Texas, United States and 231 other locations

This is a single arm, open-label, multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in de novo HR pediatric and y...

Active, not recruiting
B-Cell Acute Lymphoblastic Leukemia
Biological: CTL019

Phase 2

Novartis
Novartis

San Antonio, Texas, United States and 43 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems